Abstract

To effectively translate bioactive scaffolds into a preclinical setting, proper sterilization techniques and storage conditions need to be carefully considered, as the chosen sterilization technique and storage condition might affect the structural and mechanical properties of the scaffolds, as well as the bioactivity and release kinetics of the incorporated biomolecules. Since rarely tested or quantified, we show here in a proof-of-concept study how these parameters are affected by UV sterilization and one week storage at different temperatures using bioactive electrospun DegraPol scaffolds that were specifically designed for application in the field of tendon rupture repair. Even though UV sterilization and the different storage conditions did not impact the morphology or the physicochemical properties of the bioactive scaffolds, UV sterilization caused significant attenuation of the growth factor release kinetics, here platelet derived growth factor (PDGF-BB) release (by approx. 85%) and slight decrease in ascorbic acid release (by approx. 20%). In contrast, 4 °C and −20 °C storage did not have a major effect on the release kinetics of PDGF-BB, while storage at room temperature caused increase in PDGF-BB released. All storage conditions had little effect on ascorbic acid release. Equally important, neither UV sterilization nor storage affected the bioactivity of the released PDGF-BB, suggesting stability of the bioactive scaffolds for at least one week and showing potential for bioactive DegraPol scaffolds to be translated into an off-the-shelf available product. These parameters are expected to be scaffold and protein-dependent.

Highlights

  • Sterilization and storage of bioactive emulsion electrospun DP scaffolds

  • These data are promising as they show the potential for bioactive DegraPol scaffolds to be translated into an off-the-shelf available product

  • It is expected though that each of the parameters tested here depends on the material properties, how it is processed into a scaffold and on the biochemical and biophysical properties of the drug that is released

Read more

Summary

Introduction

Sterilization and storage of bioactive emulsion electrospun DP scaffolds. Bioactive emulsion electrospun scaffolds with incorporated PDGF-BB or ascorbic acid were produced with emulsion electrospinning and were dried overnight under vacuum. Emulsion electrospun DP scaffolds not sterilized or UV sterilized, without and with incorporated PDGF-BB or ascorbic acid were characterized with FTIR.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call